Related Experiment Video
Updated: Mar 11, 2026
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)
Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging
Published on: July 1, 2021
The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue
Shogo Wada1, Michael Neinast1, Cholsoon Jang1,2
1Department of Medicine and Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Abstract:
Noncanonical mechanistic target of rapamycin (mTOR) pathways remain poorly understood. Mutations in the tumor suppressor folliculin (FLCN) cause Birt-Hogg-Dubé syndrome, a hamartomatous disease marked by mitochondria-rich kidney tumors. FLCN functionally interacts with mTOR and is expressed in most tissues, but its role in fat has not been explored. We show here that FLCN regulates adipose tissue browning via mTOR and the transcription factor TFE3. Adipose-specific deletion of FLCN relieves mTOR-dependent cytoplasmic retention of TFE3, leading to direct induction of the PGC-1 transcriptional coactivators, drivers of mitochondrial biogenesis and the browning program. Cytoplasmic retention of TFE3 by mTOR is sensitive to ambient amino acids, is independent of growth factor and tuberous sclerosis complex (TSC) signaling, is driven by RagC/D, and is separable from canonical mTOR signaling to S6K. Codeletion of TFE3 in adipose-specific FLCN knockout animals rescues adipose tissue browning, as does codeletion of PGC-1β. Conversely, inducible expression of PGC-1β in white adipose tissue is sufficient to induce beige fat gene expression in vivo. These data thus unveil a novel FLCN-mTOR-TFE3-PGC-1β pathway-separate from the canonical TSC-mTOR-S6K pathway-that regulates browning of adipose tissue.
Insights
Folliculin (FLCN) regulates fat browning through a novel mechanistic target of rapamycin (mTOR) pathway involving TFE3 and PGC-1β. This pathway is distinct from the canonical TSC-mTOR-S6K pathway.
Area of Science:
- Cell Biology
- Metabolism
- Molecular Biology
Background:
- Noncanonical mechanistic target of rapamycin (mTOR) pathways are not well understood.
- Mutations in tumor suppressor folliculin (FLCN) cause Birt-Hogg-Dubé syndrome, characterized by kidney tumors.
- FLCN's role in adipose tissue has not been previously explored.
Purpose of the Study:
- To investigate the role of folliculin (FLCN) in regulating adipose tissue browning.
- To elucidate the molecular mechanisms by which FLCN influences adipose tissue metabolism.
- To identify novel pathways regulating adipose tissue browning.
Main Methods:
- Adipose-specific deletion of FLCN in animal models.
- Analysis of mTOR signaling and TFE3 localization.
- Assessment of PGC-1 transcriptional coactivators and adipose tissue browning markers.
- Genetic manipulation of TFE3 and PGC-1β expression.
Main Results:
- FLCN deletion in adipose tissue leads to TFE3 release from mTOR-dependent cytoplasmic retention.
- This results in the induction of PGC-1 coactivators, driving mitochondrial biogenesis and adipose tissue browning.
- The FLCN-mTOR-TFE3-PGC-1β pathway is independent of canonical TSC-mTOR-S6K signaling.
- Codeletion of TFE3 or PGC-1β rescues adipose tissue browning in FLCN knockout models.
Conclusions:
- A novel FLCN-mTOR-TFE3-PGC-1β pathway regulates adipose tissue browning.
- This pathway is distinct from the canonical TSC-mTOR-S6K pathway.
- FLCN plays a critical role in controlling adipose tissue metabolism and energy expenditure.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
TGF - β Signaling Pathway